Limitation on Information. We generally provide information to our clients (whether orally or in writing) on products, services or transactions offered by us or general market information, but we give no representation, warranty or guarantee as to its accuracy or completeness or as to any tax consequences or accounting treatment.
Limitation on Information. None of the Seller Parties or any of their respective Affiliates has made or makes any representation as to the Company.
Limitation on Information. The term Information shall not include information that, other than by breach of this Agreement by Recipient or its Representatives: (i) is or becomes available to the public other than as a result of a disclosure by the Recipient or its Representatives in breach of this Agreement, (ii) is in lawful possession of the Recipient on a non-confidential basis prior to disclosure by Company or Company’s Representatives, (iii) is obtained from a third party who is not known, after a reasonable inquiry, by Recipient to be prohibited from disclosing such information, or (iv) is developed by Recipient or its Representatives independently of the Information received from Company.
Limitation on Information. The term Information shall not include information that, other than by breach of this Agreement: (i) is or becomes available to the public other than as a result of a disclosure by Recipient and/or its Representatives in violation of this Agreement, (ii) is in lawful possession of Recipient prior to disclosure by Company or Company’s Representatives, (iii) is obtained from a Person who is not known by Recipient to be prohibited from disclosing such information, or (iv) is developed by Recipient or its Representatives independently of the Information received from Company.
Limitation on Information. Following such Change of Control, Lilly shall have the right to (i) limit the information or reports otherwise required to be provided to Sigilon or the JRC hereunder to only that which is essential to ensure Lilly’s compliance with its obligations hereunder and Lilly shall have the right to refrain from including in such information or reports commercially sensitive information of Lilly (as Lilly may determine in good faith), and (ii) cause Sigilon (or Competing Acquirer) to assign (or otherwise provide the full benefit of) any agreement(s) with any Third Party(ies) related to the research, Development, Manufacture, Commercialization or other exploitation of the Licensed Product in the event Lilly exercises its rights under Section 15.8.3(a).
Limitation on Information. Until the Disclosure Date, Ascena agrees that it will not seek any information from Opus that this Addendum restricts Opus from providing to Ascena, including without limitation the EBITDA for any individual Store in the Test Batch or the name of any landlord for a particular Store or the name or location of any Store, except to the extent such disclosure is permitted herein. After the Disclosure Date, Ascena shall have access to any Copies or other information previously supplied to Opus.
Limitation on Information. Following such Change of Control, Lilly shall have the right to (i) limit the information or reports otherwise required to be provided to Aduro or the JRC hereunder to only that which is essential to ensure Aduro’s compliance with its obligations hereunder and Lilly shall have the right to refrain from including in such information or reports commercially sensitive information of Lilly (as Lilly may determine in its sole discretion), and (ii) in the event Lilly exercises its rights under Section 15.10.3(c), Lilly may cause Aduro (or the Competing Acquirer) to assign (or otherwise provide the full benefit of) any agreement(s) between Aduro and any Third Party(ies) related to the Research, Development, Manufacture, Commercialization or other exploitation of the Product that existed prior to the consummation of such Competing Acquisition. Without limiting the foregoing, in the event that either Party has a good faith concern that sharing of information following such Change of Control is prohibited under Applicable Law, the Parties shall promptly meet to discuss such concern.
Limitation on Information. None of the Seller Parties or any of their respective Affiliates (1) has been requested to or has provided the Purchaser with any information or advice with respect to the Purchased Shares nor is such information or advice necessary or desired, or (2) has made or makes any representation as to the Company.
